HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Color additive market exclusivity

This article was originally published in The Rose Sheet

Executive Summary

Color additive market exclusivity: Food and color additive market exclusivity was "briefly discussed" by the Senate Labor and Human Resources Committee as "an incentive for research and development of new food and color additive products," according to the June 20 committee report on the Senate FDA reform bill (S 1477). The provision would be similar to the existing market exclusivity law that applies to prescription drugs, the report says. The idea was never formally introduced to the committee, according to the report, but "several members" indicated they were interested in pursuing the "matter further"...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002954

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel